| abstract |
FIELD: medicine. SUBSTANCE: solution contains at least one osmotically active ingredient selected from acetylated amino sugar, deacetylated amino sugar, or their combinations. The agent is taken as monomer or oligomer having 2 to 12 carbohydrate links. N- acetylgalactosamine, N-acetylglucosamine, N-acetylmannosamine, glucosamine, galactosamine, mannosamine are usable as the agent. The solution optionally contains electrolytes like Na, Cl, Ca, Mg, lactate, malate, acetate, succinate, or their combinations. It has pH of 5.0-7.4. Method for performing peritoneal analysis involves introducing the solution into the peritoneal cavity. Method for treating the patient on the occasion of renal insufficiency involves introducing the solution into the peritoneal cavity of the patient. EFFECT: improved biocompatibility properties; avoided morphological or functional disorders of the peritoneal membrane; prolonged period of treatment. 28 cl, 2 tbl |